Investments
128Portfolio Exits
41Funds
10Partners & Customers
2Service Providers
1About Gilde Healthcare
Gilde Healthcare is a healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture and growth capital fund. The company's lower mid-market buy-out fund invests in European healthcare companies with a focus on the Netherlands, Belgium, and Germany. Its portfolio consists of healthcare providers, suppliers of medical products, and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health, and therapeutics. The company was founded in 1982 and is based in Utrecht, Netherlands.
Latest Gilde Healthcare News
Nov 21, 2023
Gilde Healthcare has acquired Koscher & Würtz (K&W), a German precision surgical instruments manufacturer. K&W will join Gilde’s portfolio company Chr. Diener, and the combined entity will employ about 300 staff members. Gilde’s private equity fund invested in Chr. Diener in July last year. Chr. Diener has been manufacturing surgical instruments since 1900 and is headquartered in Tuttlingen, Germany. According to Gilde Healthcare, the aim of the transaction is to create a leading contract manufacturer of precision medical instruments. Headquartered in Spaichingen, Germany, K&W develops and manufactures reusable and disposable surgical instruments for original equipment manufacturers. It was founded in 1983. Gilde Healthcare is a specialised healthcare investor managing more than €2.6bn across two fund strategies: venture and growth, and private equity.
Gilde Healthcare Investments
128 Investments
Gilde Healthcare has made 128 investments. Their latest investment was in Tagworks Pharmaceuticals as part of their Series A on June 6, 2023.
Gilde Healthcare Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/22/2023 | Series A | Tagworks Pharmaceuticals | $65M | Yes | 5 | |
4/4/2023 | Series A - II | ADCendo | $33.87M | No | 6 | |
3/23/2023 | Series C | GT Medical Technologies | $45M | Yes | 8 | |
3/15/2023 | Series A | |||||
3/15/2023 | Series C - II |
Date | 6/22/2023 | 4/4/2023 | 3/23/2023 | 3/15/2023 | 3/15/2023 |
|---|---|---|---|---|---|
Round | Series A | Series A - II | Series C | Series A | Series C - II |
Company | Tagworks Pharmaceuticals | ADCendo | GT Medical Technologies | ||
Amount | $65M | $33.87M | $45M | ||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 5 | 6 | 8 |
Gilde Healthcare Portfolio Exits
41 Portfolio Exits
Gilde Healthcare has 41 portfolio exits. Their latest portfolio exit was Zetacom on February 15, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/15/2023 | Acq - Fin | 1 | |||
12/14/2021 | Acquired | 5 | |||
11/22/2021 | Acquired | 6 | |||
Date | 2/15/2023 | 12/14/2021 | 11/22/2021 | ||
|---|---|---|---|---|---|
Exit | Acq - Fin | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 5 | 6 |
Gilde Healthcare Acquisitions
14 Acquisitions
Gilde Healthcare acquired 14 companies. Their latest acquisition was Koscher & Wurtz on November 20, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
11/20/2023 | Acq - Fin | 1 | ||||
8/29/2022 | Acquired Unit - Fin | 2 | ||||
7/5/2022 | Acq - Fin | 1 | ||||
2/11/2022 | ||||||
12/6/2021 |
Date | 11/20/2023 | 8/29/2022 | 7/5/2022 | 2/11/2022 | 12/6/2021 |
|---|---|---|---|---|---|
Investment Stage | |||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acq - Fin | Acquired Unit - Fin | Acq - Fin | ||
Sources | 1 | 2 | 1 |
Gilde Healthcare Fund History
10 Fund Histories
Gilde Healthcare has 10 funds, including Gilde Healthcare Private Equity IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
3/16/2022 | Gilde Healthcare Private Equity IV | $568.39M | 2 | ||
3/31/2020 | Gilde Healthcare V | $458.05M | 2 | ||
3/7/2019 | Gilde Healthcare III | Late-Stage Venture Capital | Closed | $225.19M | 2 |
3/7/2019 | Gilde Healthcare Services III | ||||
6/14/2016 | Gilde Healthcare IV |
Closing Date | 3/16/2022 | 3/31/2020 | 3/7/2019 | 3/7/2019 | 6/14/2016 |
|---|---|---|---|---|---|
Fund | Gilde Healthcare Private Equity IV | Gilde Healthcare V | Gilde Healthcare III | Gilde Healthcare Services III | Gilde Healthcare IV |
Fund Type | Late-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | $568.39M | $458.05M | $225.19M | ||
Sources | 2 | 2 | 2 |
Gilde Healthcare Partners & Customers
2 Partners and customers
Gilde Healthcare has 2 strategic partners and customers. Gilde Healthcare recently partnered with NIZO food research on March 3, 2016.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
3/7/2016 | Partner | Netherlands | NIZO and Gilde Healthcare join forces for growth - NIZO food research Home / News / NIZO and Gilde Healthcare join forces for growth . | 1 | |
1/7/2014 | Partner |
Date | 3/7/2016 | 1/7/2014 |
|---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | Netherlands | |
News Snippet | NIZO and Gilde Healthcare join forces for growth - NIZO food research Home / News / NIZO and Gilde Healthcare join forces for growth . | |
Sources | 1 |
Gilde Healthcare Service Providers
1 Service Provider
Gilde Healthcare has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Acquired | Investment Bank | Financial Advisor |
Service Provider | |
|---|---|
Associated Rounds | Acquired |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
Gilde Healthcare Team
11 Team Members
Gilde Healthcare has 11 team members, including current Founder, Managing Partner, Edwin De Graaf.
Loading...